Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-17

Clinical Trial Update: MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 randomized, placebo-controlled, double-blind crossover study evaluating melatonin used topically as a sunscreen (MELATOX) in healthy volunteers; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELATOX (melatonin)

Snippet

Sponsor: Zealand University Hospital | Conditions: Solar Skin Damage | Phase 1 | Status: COMPLETED